Net income 2018
Net income 2019
P/E ratio 2018
P/E ratio 2019
Capi. / Sales2018
Capi. / Sales2019
Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. Its lead drug Rintega (also referred to as rindopepimut and CDX-110) is a therapeutic...
Latest news on CELLDEX THERAPEUTICS, INC.
Analyst Recommendations on CELLDEX THERAPEUTICS, INC.
Sector news : Biotechnology & Medical Research - NEC
Chart CELLDEX THERAPEUTICS, INC.
Technical analysis trends CELLDEX THERAPEUTICS, INC.
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Number of Analysts
Average target price
Spread / Average Target